Docking of Noncompetitive Inhibitors into Dengue Virus Type 2 Protease: Understanding the Interactions with Allosteric Binding Sites

A group of flavanones and their chalcones, isolated from Boesenbergia rotunda L., were previously reported to show varying degrees of noncompetitive inhibitory activities toward Dengue virus type 2 (Den2) protease. Results obtained from automated docking studies are in agreement with experimental data in which the ligands were shown to bind to sites other than the active site of the protease. The calculated K(i) values are very small, indicating that the ligands bind quite well to the allosteric binding site. Greater inhibition by pinostrobin, compared to the other compounds, can be explained by H-bonding interaction with the backbone carbonyl of Lys74, which is bonded to Asp75 (one of the catalytic triad residues). In addition, structure-activity relationship analysis yields structural information that may be useful for designing more effective therapeutic drugs against dengue virus infections.

[1]  J M Thornton,et al.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.

[2]  R. Doms,et al.  Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo , 2005, Journal of Virology.

[3]  S. Karlin,et al.  Geometry of interplanar residue contacts in protein structures. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Ray,et al.  Recent advances in flavivirus antiviral drug discovery and vaccine development. , 2006, Recent patents on anti-infective drug discovery.

[5]  G. Petsko,et al.  Weakly polar interactions in proteins. , 1988, Advances in protein chemistry.

[6]  R. Yusof,et al.  Purified NS2B/NS3 Serine Protease of Dengue Virus Type 2 Exhibits Cofactor NS2B Dependence for Cleavage of Substrates with Dibasic Amino Acids in Vitro* , 2000, The Journal of Biological Chemistry.

[7]  Scott F Michael,et al.  Peptide inhibitors of dengue virus and West Nile virus infectivity , 2005, Virology Journal.

[8]  P. Frey,et al.  A low-barrier hydrogen bond in the catalytic triad of serine proteases. , 1994, Science.

[9]  P. Carloni,et al.  Serine proteases: An ab initio molecular dynamics study , 1999, Proteins.

[10]  M. Diamond,et al.  Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. , 2002, Virology.

[11]  D. van der Spoel,et al.  Efficient docking of peptides to proteins without prior knowledge of the binding site , 2002, Protein science : a publication of the Protein Society.

[12]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[13]  J. Thornton,et al.  Satisfying hydrogen bonding potential in proteins. , 1994, Journal of molecular biology.

[14]  D. Fairlie,et al.  Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor. , 1999, The Journal of general virology.

[15]  M F Sanner,et al.  Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.

[16]  M. Shoja.  5-Hydroxy-7-methoxyflavone , 1989 .

[17]  Claudio N. Cavasotto,et al.  Representing receptor flexibility in ligand docking through relevant normal modes. , 2005, Journal of the American Chemical Society.

[18]  S. Tewtrakul,et al.  HIV-1 protease inhibitory effects of medicinal plants used as self medication by AIDS patients , 2003 .

[19]  M. Hunkapiller,et al.  Mechanism of action of serine proteases: tetrahedral intermediate and concerted proton transfer. , 1976, Biochemistry.

[20]  R. Fletterick,et al.  Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses. , 1989, Virology.

[21]  J. H. Strauss,et al.  Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain. , 1993, Virology.

[22]  D. Vaughn,et al.  An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. , 2005, Vaccine.

[23]  P. Tuchinda,et al.  Anti-inflammatory cyclohexenyl chalcone derivatives in Boesenbergia pandurata. , 2002, Phytochemistry.

[24]  Francesco Luigi Gervasio,et al.  The nature of intermolecular interactions between aromatic amino acid residues , 2002, Proteins.

[25]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[26]  C. Lai,et al.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins , 1991, Journal of virology.

[27]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[28]  T. Mak,et al.  A novel 1:1 complex of potassium mikanin-3-O-sulfate with methanol. , 2001, Chemical & pharmaceutical bulletin.

[29]  K E Ebner,et al.  Cotranslational Membrane Insertion of the Serine Proteinase Precursor NS2B-NS3(Pro) of Dengue Virus Type 2 Is Required for Efficient in Vitro Processing and Is Mediated through the Hydrophobic Regions of NS2B* , 1997, The Journal of Biological Chemistry.

[30]  M. Robinson,et al.  Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention. , 1997, The Journal of pediatrics.

[31]  D. Gubler.  The global emergence/resurgence of arboviral diseases as public health problems. , 2002, Archives of medical research.

[32]  Y. Sasaguri,et al.  Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain). , 1989, Gene.

[33]  J. Puripattanavong,et al.  HIV-1 protease inhibitory substances from the rhizomes of Boesenbergia pandurata Holtt. , 2003 .

[34]  Pedro Alexandrino Fernandes,et al.  Protein–ligand docking: Current status and future challenges , 2006, Proteins.

[35]  V. Blinov,et al.  N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. , 1989, Nucleic acids research.

[36]  David Beer,et al.  Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead. , 2006, Bioorganic & medicinal chemistry letters.

[37]  Zheng Yin,et al.  Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus , 2006, Nature Structural &Molecular Biology.